Pancreatic Cancer Research

ResearcherNavarre Institute of Health ResearchActive in the last 2 years

Hugo Arasanz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6838-6702; OpenAlex author ID A5049468211. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-024-67235-y↗
  2. Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition. Co-author DOI 10.3390/cancers12082181↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Iranzu González‐Borja · 1 shared paper, 2024 · strength 0.17
  2. Antonio Viúdez · 1 shared paper, 2024 · strength 0.17
  3. Ibone Labiano · 1 shared paper, 2024 · strength 0.17
  4. Ruth Vera · 1 shared paper, 2024 · strength 0.17
  5. Joaquín Fernández‐Irigoyen · 1 shared paper, 2020 · strength 0.09
  6. Grazyna T. Kochan · 1 shared paper, 2020 · strength 0.09
  7. Ruth Vera · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.